Authors: RONDELLI D RASPADORI D ANASETTI C BANDINI G RE F ARPINATI M STANZANI M MORELLI A BACCINI C ZACCARIA A LEMOLI RM TURA S

Citation: D. Rondelli et al., ALLOANTIGEN PRESENTING CAPACITY, T-CELL ALLOREACTIVITY AND NK FUNCTION OF G-CSF-MOBILIZED PERIPHERAL-BLOOD CELLS, Bone marrow transplantation, 22(7), 1998, pp. 631-637

Authors: BANDINI B RONDELLI D STANZANI M LEMOLI R LEOPARDI G BONIFAZI F REMIDDI C ROSTI G RIZZI S TURA S

Citation: B. Bandini et al., CONCURRENT AND PROSPECTIVE ANALYSIS OF ALLOGENIC PBSC AND BONE-MARROWTRANSPLANTATION (BMT) FOR HEMATOLOGICAL MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 154-154

Authors: LEOPARDI G BANDINI G LEMOLI RM CAMPANINI E RONDELLI D STANZANI M BONINI A TURA S

Citation: G. Leopardi et al., IS GVHD FOLLOWING ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANT (PBSCT) DIFFERENT FROM THAT OF MARROW TRANSPLANT, Bone marrow transplantation, 21, 1998, pp. 426-426

Authors: RE F RONDELLI D RASPADORI D BANDINI G BONINI A LEOPARDI G CIMARELLI S STANZANI M TURA S

Citation: F. Re et al., DIFFERENT IMMUNOLOGICAL RECONSTITUTION FOLLOWING ALLOGENEIC PBSC TRANSPLANTATION IN AML, CML AND MM PATIENTS, Bone marrow transplantation, 21, 1998, pp. 467-467

Authors: STANZANI M BANDINI B ROSTI G LEOPARDI G REMIDDI C BONINI A MANGIANTI S TURA S

Citation: M. Stanzani et al., A POLICY OF WAIT AND SEE FOR CYTOMEGALOVIRUS ANTIGEMIA POSITIVITY (CMV AG-MARROW TRANSPLANTATION (BMT)() AFTER ALLOGENEIC BONE), Bone marrow transplantation, 21, 1998, pp. 491-491